Brief: Selvita Unit Receives EUR 3.3 Mln Order For Drug Analytical Work
30/03/2026 06:27
March 30 (Reuters) - Selvita SA SLV1.WA: UNIT SELVITA SERVICES RECEIVES ORDER FROM EUROPEAN BIOPHARMACEUTICAL FIRM ESTIMATED VALUE OF ORDER IS EUR 3.3 MILLION ORDER IS FOR ANALYTICAL WORK TO SUPPORT COMMERCIALIZATION OF A BIOLOGICAL DRUG TOTAL ESTIMATED VALUE OF COOPERATION WITH CLIENT IN 2026 TO REACH EUR 5.4 MILLION Source text for Workspace: nEM9PvwCDa Further company coverage: SLV1.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Selvita SA
See all newsBrief: Selvita Units Selvita Services And Pozlab Sign Merger Plan
Brief: Selvita Appoints Rafal Chwast As CEO
Brief: Selvita Q2 Net Loss At 3.0 Mln Zlotys
Brief: Selvita Receives Significant Order From European Biopharmaceutical Company Worth Up to €5 Million
Brief: Selvita Q1 Net Loss At 5.5 Million Zlotys